• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪氨酸-苯丁酸氮芥缀合物通过人乳腺癌细胞系 MCF-7 中的 L 型氨基酸转运蛋白 1(LAT1)促进细胞摄取。

Tyrosine-Chlorambucil Conjugates Facilitate Cellular Uptake through L-Type Amino Acid Transporter 1 (LAT1) in Human Breast Cancer Cell Line MCF-7.

机构信息

Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.

Human High Performance and Health Promotion Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.

出版信息

Int J Mol Sci. 2020 Mar 20;21(6):2132. doi: 10.3390/ijms21062132.

DOI:10.3390/ijms21062132
PMID:32244913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7139360/
Abstract

l-type amino acid transporter 1 (LAT1) is an amino acid transporter that is overexpressed in several types of cancer and, thus, it can be a potential target for chemotherapy. The objectives of this study were to (a) synthesize LAT1-targeted chlorambucil derivatives and (b) evaluate their LAT1-mediated cellular uptake as well as antiproliferative activity in vitro in the human breast cancer MCF-7 cell line. Chlorambucil was conjugated to l-tyrosine-an endogenous LAT1 substrate-via either ester or amide linkage (compounds and , respectively). While chlorambucil itself did not bind to LAT1, its derivatives and bound to LAT1 with a similar affinity as with l-tyrosine and their respective cellular uptake was significantly higher than that of chlorambucil in MCF-7. The results of our cellular uptake study are indicative of antiproliferative activity, as a higher intracellular uptake of chlorambucil derivatives resulted in greater cytotoxicity than chlorambucil by itself. LAT1 thus contributes to intracellular uptake of chlorambucil derivatives and, therefore, increases antiproliferative activity. The understanding gained from our research can be used in the development of LAT1-targeted anticancer drugs and prodrugs for site-selective and enhanced chemotherapeutic activity.

摘要

L 型氨基酸转运蛋白 1(LAT1)是一种在多种癌症中过度表达的氨基酸转运蛋白,因此它可能成为化疗的潜在靶点。本研究的目的是:(a)合成 LAT1 靶向的苯丁酸氮芥衍生物;(b)评估它们在体外人乳腺癌 MCF-7 细胞系中的 LAT1 介导的细胞摄取和抗增殖活性。通过酯或酰胺键将苯丁酸氮芥与内源性 LAT1 底物 l-酪氨酸偶联(化合物 和 )。苯丁酸氮芥本身不与 LAT1 结合,但它的衍生物 和 与 LAT1 的结合亲和力与 l-酪氨酸相似,其各自的细胞摄取率明显高于苯丁酸氮芥在 MCF-7 中的摄取率。我们的细胞摄取研究结果表明具有抗增殖活性,因为 LAT1 衍生物的更高细胞内摄取导致比苯丁酸氮芥本身更高的细胞毒性。因此,LAT1 有助于苯丁酸氮芥衍生物的细胞内摄取,从而提高了抗增殖活性。我们的研究成果可用于开发 LAT1 靶向的抗癌药物和前药,以实现位点选择性和增强的化疗活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/999190ac49de/ijms-21-02132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/3f409e171268/ijms-21-02132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/b4a60e8d1175/ijms-21-02132-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/caa359dba395/ijms-21-02132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/cfdfb893f0f2/ijms-21-02132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/d4f487a41b66/ijms-21-02132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/999190ac49de/ijms-21-02132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/3f409e171268/ijms-21-02132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/b4a60e8d1175/ijms-21-02132-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/caa359dba395/ijms-21-02132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/cfdfb893f0f2/ijms-21-02132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/d4f487a41b66/ijms-21-02132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cb/7139360/999190ac49de/ijms-21-02132-g005.jpg

相似文献

1
Tyrosine-Chlorambucil Conjugates Facilitate Cellular Uptake through L-Type Amino Acid Transporter 1 (LAT1) in Human Breast Cancer Cell Line MCF-7.酪氨酸-苯丁酸氮芥缀合物通过人乳腺癌细胞系 MCF-7 中的 L 型氨基酸转运蛋白 1(LAT1)促进细胞摄取。
Int J Mol Sci. 2020 Mar 20;21(6):2132. doi: 10.3390/ijms21062132.
2
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.用于选择性和高效的 l 型氨基酸转运体 1(LAT1)介导的细胞摄取的结构特性。
Int J Pharm. 2018 Jun 10;544(1):91-99. doi: 10.1016/j.ijpharm.2018.04.025. Epub 2018 Apr 15.
3
Amino acid ester prodrugs conjugated to the α-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1).与α-羧酸基团共轭的氨基酸酯前药对L型氨基酸转运体1(LAT1)没有亲和力。
Eur J Pharm Sci. 2015 Jan 23;66:36-40. doi: 10.1016/j.ejps.2014.09.025. Epub 2014 Oct 8.
4
Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.芳烃受体(AHR)对MCF-7和MDA-MB-231乳腺癌细胞中L型氨基酸转运体1(LAT-1)表达的调控
Biochem Pharmacol. 2016 Apr 15;106:94-103. doi: 10.1016/j.bcp.2016.02.020. Epub 2016 Mar 2.
5
Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.肿瘤上调的 L 型氨基酸转运蛋白 1 对 3-氟-L-α-甲基酪氨酸的转运:导致 PET 肿瘤摄取的原因。
J Nucl Med. 2012 Aug;53(8):1253-61. doi: 10.2967/jnumed.112.103069. Epub 2012 Jun 28.
6
Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB for efficient tumor therapy.酪氨酸修饰的载伊立替康脂质体能够同时靶向 LAT1 和 ATB,实现高效的肿瘤治疗。
J Control Release. 2019 Dec 28;316:22-33. doi: 10.1016/j.jconrel.2019.10.037. Epub 2019 Oct 30.
7
Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: Toward a novel active targeting strategy in breast cancer therapy.用氨基酸修饰的纳米颗粒靶向肿瘤高表达的LAT1转运体:迈向乳腺癌治疗中的一种新型主动靶向策略。
Nanomedicine. 2017 Apr;13(3):987-998. doi: 10.1016/j.nano.2016.11.012. Epub 2016 Nov 25.
8
L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.L 型氨基酸转运体 1 利用阿魏酸前药揭示了支持脑递药前药设计的结构特征。
Eur J Pharm Sci. 2019 Mar 1;129:99-109. doi: 10.1016/j.ejps.2019.01.002. Epub 2019 Jan 6.
9
PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x) with [F]FDOPA and [F]FSPG in Breast Cancer Models.正电子发射断层扫描成像技术(PET)对 L 型氨基酸转运蛋白(LAT1)和胱氨酸-谷氨酸逆向转运蛋白(xCT)的研究:以[F]FDOPA 和 [F]FSPG 作为示踪剂在乳腺癌模型中的应用。
Mol Imaging Biol. 2020 Dec;22(6):1562-1571. doi: 10.1007/s11307-020-01529-1. Epub 2020 Aug 13.
10
L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism.L 型氨基酸转运蛋白 1 通过促进氨基酸代谢与乳腺癌的化疗耐药性相关。
Sci Rep. 2021 Jan 12;11(1):589. doi: 10.1038/s41598-020-80668-5.

引用本文的文献

1
One Change, Many Benefits: A Glycine-Modified Bacteriochlorin with NIR Absorption and a Type I Photochemical Mechanism for Versatile Photodynamic Therapy.一变多利:一种具有近红外吸收和I型光化学机制的甘氨酸修饰细菌叶绿素用于多功能光动力疗法
Int J Mol Sci. 2024 Dec 6;25(23):13132. doi: 10.3390/ijms252313132.
2
Synthesis, Cytotoxicity, and Mechanistic Evaluation of Tetrahydrocurcumin-Amino Acid Conjugates as LAT1-Targeting Anticancer Agents in C6 Glioma Cells.四氢姜黄素-氨基酸缀合物的合成、细胞毒性及作为 C6 神经胶质瘤细胞中 LAT1 靶向抗癌剂的作用机制评价。
Int J Mol Sci. 2024 Oct 19;25(20):11266. doi: 10.3390/ijms252011266.
3

本文引用的文献

1
The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.L 型氨基酸转运蛋白 LAT1:癌症治疗的新兴靶点
Int J Mol Sci. 2019 May 16;20(10):2428. doi: 10.3390/ijms20102428.
2
Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods.基于结构的方法发现大型中性氨基酸转运蛋白 1(LAT1)的有效抑制剂。
Int J Mol Sci. 2018 Dec 21;20(1):27. doi: 10.3390/ijms20010027.
3
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).重新评估 L 型氨基酸转运体(LAT1)的底物特异性。
Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents.
含氯苯丁酸的杂交分子在潜在抗癌药物研发中的应用。
Molecules. 2023 Sep 30;28(19):6889. doi: 10.3390/molecules28196889.
4
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy.溶质载体转运体在高效抗癌药物递送与治疗中的作用
Pharmaceutics. 2023 Jan 21;15(2):364. doi: 10.3390/pharmaceutics15020364.
5
Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma.开发 Sesamol 氨基甲酸酯-L-苯丙氨酸前药,靶向 L 型氨基酸转运蛋白 1(LAT1),作为一种潜在的抗黑色素瘤增殖剂。
Int J Mol Sci. 2022 Jul 30;23(15):8446. doi: 10.3390/ijms23158446.
6
Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.LAT1-4F2hc通过Toll样受体及其他重要途径在泌尿系统癌症中的作用
Cancers (Basel). 2022 Jan 4;14(1):229. doi: 10.3390/cancers14010229.
7
Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells.谷氨酰胺及其代谢产物氨在癌症相关成纤维细胞与癌细胞相互作用中的作用
Cancer Cell Int. 2021 Sep 9;21(1):479. doi: 10.1186/s12935-021-02121-5.
J Med Chem. 2018 Aug 23;61(16):7358-7373. doi: 10.1021/acs.jmedchem.8b01007. Epub 2018 Aug 10.
4
Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.苯丙氨酸通过破坏细胞内氨基酸稳态和触发氨基酸应答途径抑制乳腺癌细胞生长。
BMC Cancer. 2018 Jun 26;18(1):689. doi: 10.1186/s12885-018-4599-8.
5
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.用于选择性和高效的 l 型氨基酸转运体 1(LAT1)介导的细胞摄取的结构特性。
Int J Pharm. 2018 Jun 10;544(1):91-99. doi: 10.1016/j.ijpharm.2018.04.025. Epub 2018 Apr 15.
6
Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.氮芥作为烷化抗癌药物的治疗历程:从历史到未来展望。
Eur J Med Chem. 2018 May 10;151:401-433. doi: 10.1016/j.ejmech.2018.04.001. Epub 2018 Apr 3.
7
L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.L 型氨基酸转运体 1 利用前药:如何实现药物的有效脑递送和低系统暴露。
J Control Release. 2017 Sep 10;261:93-104. doi: 10.1016/j.jconrel.2017.06.023. Epub 2017 Jun 27.
8
A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.两种已批准药物顺铂和苯丁酸氮芥的前药,用于癌症的化疗战争。
Mol Cancer Ther. 2017 Apr;16(4):625-636. doi: 10.1158/1535-7163.MCT-16-0445. Epub 2017 Feb 1.
9
Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.靶向L型氨基酸转运体的癌症治疗新方法。
World J Gastrointest Oncol. 2017 Jan 15;9(1):21-29. doi: 10.4251/wjgo.v9.i1.21.
10
Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure.氨基酸部分改变丙戊酸的药代动力学并延长脑部暴露时间。
Neurochem Res. 2016 Oct;41(10):2797-2809. doi: 10.1007/s11064-016-1996-8. Epub 2016 Jul 14.